4 results match your criteria: "and Stony Brook University Medical Center[Affiliation]"
Tranexamic Acid Use in United States Trauma Centers: A National Survey.
Am Surg
May 2016
Division of Trauma, Department of Surgery, Stony Brook University School of Medicine and Stony Brook University Medical Center, Stony Brook, New York, USA.
Tranexamic acid (TXA) is an antifibrinolytic agent that is listed as an essential medication by the World Health Organization for traumatic hemorrhage. We determined United States-based surgeons' familiarity with TXA and their use of TXA. An online survey was sent to the 1291 attending surgeon members of a national trauma organization.
View Article and Find Full Text PDFAssessment of American College of Rheumatology-Endorsed Quality Indicators in Rheumatoid Arthritis Patients: A Quality Improvement Initiative.
J Clin Rheumatol
March 2016
From the *North Shore-LIJ Health System, NY; †University of Texas Southwestern Medical Center, Dallas, TX; and ‡Stony Brook University Medical Center, Stony Brook, NY.
Background: The American College of Rheumatology endorses 7 rheumatoid arthritis (RA) quality indicators (QIs), which we used to access quality of care at our institution.
Objective: The aim of this study was to assess the quality of care provided to RA patients at our outpatient rheumatology practice based on adherence to 7 QIs.
Methods: We performed a retrospective paper chart review and included 356 RA patients to determine adherence to each QI.
Patient acceptance of non-invasive testing for fetal aneuploidy via cell-free fetal DNA.
J Matern Fetal Neonatal Med
January 2014
Department of Obstetrics and Gynecology, Winthrop University Hospital, Mineola, and Stony Brook University Medical Center, Stony Brook, NY , USA.
Objective: To evaluate factors associated with patient acceptance of noninvasive prenatal testing for trisomy 21, 18 and 13 via cell-free fetal DNA.
Methods: This was a retrospective study of all patients who were offered noninvasive prenatal testing at a single institution from 1 March 2012 to 2 July 2012. Patients were identified through our perinatal ultrasound database; demographic information, testing indication and insurance coverage were compared between patients who accepted the test and those who declined.
Voice recognition technology implementation in surgical pathology: advantages and limitations.
Arch Pathol Lab Med
November 2011
Department of Pathology, State University of New York at Stony Brook and Stony Brook University Medical Center, Stony Brook, New York 11794-7025, USA.
Context: Voice recognition technology (VRT) has been in use for medical transcription outside of laboratories for many years, and in recent years it has evolved to a level where it merits consideration by surgical pathologists.
Objective: To determine the feasibility and impact of making a transition from a transcriptionist-based service to VRT in surgical pathology.
Design: We have evaluated VRT in a phased manner for sign out of general and subspecialty surgical pathology cases after conducting a pilot study.